Capsaicin research as a new tool to approach of the human gastrointestinal physiology, pathology and pharmacology

Inflammopharmacology

Volumn 15, Issue 6, 2007, Pages 232-245

  Mozsik G ^a   Szolcsanyi J ^a   Domotor A ^b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b NONE

Author keywords

Capsaicin; Gastrointestinal pathology; Gastrointestinal pharmacology; Gastrointestinal physiology; Human gastrointestinal tracts

Indexed keywords

ALCOHOL; ATROPINE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CAPSAICIN; CIMETIDINE; ESOMEPRAZOLE; FAMOTIDINE; INDOMETACIN; OMEPRAZOLE; PIRENZEPINE; RANITIDINE; SUBSTANCE P; VANILLOID RECEPTOR 1;

ADULT; AGED; ARTICLE; CHEMICAL COMPOSITION; CHRONIC GASTRITIS; CONTROLLED STUDY; DRUG MECHANISM; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRACT FUNCTION; GLUCAGON RELEASE; GLUCOSE TOLERANCE TEST; HELICOBACTER PYLORI; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENSORY NERVE; STOMACH ACID SECRETION; STOMACH EMPTYING; STOMACH INJURY; STOMACH SECRETION;

ADULT; AGED; CAPSAICIN; FEMALE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSORY SYSTEM AGENTS;

EID: 38849111792     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-007-1584-2     Document Type: Article

References (55)

1. Abdel Salam, O. M. E., Czimmer, J., Debreceni, A. et al. (2001) Gastric mucosal integrity: Gastric mucosal blood flow and microcirculation. An overview, J. Physiol. 95, 105-127.
2. Abdel Salam, O. M. E. Debreceni, A. and Mózsik, Gy. (1999) Capsaicin-sensitive afferent sensory nerves in modulating gastric mucosal defense against noxious agents, J. Physiol. 93, 443-454.
3. 2-receptor antagonist: involvement of capsaicin of sensitive sensory neurons. Inflammopharmacology 10, 483-493.
4. 2-receptor antagomist, on the recurrence of gastric ulcer healing by drug treatment. Pharmacology 61, 83-90.
5. Antal, L., Mózsik, Gy., Jávor, T., Krausz, M. (1965) The electrolyte content of gastric juice after prolonged atropine treatment. Acta Tertii Conventus Medicinae Internae Hungarici. Gastroenterologia. Akadémiai Kiadó, Budapest, 167-169.
6. Buck, SH. and Burks, TF. (1986) The neuropharmacology of capsaicin: a review of some recent observation, Pharmacol. Rev. 38, 179-226
7. Caterina, MJ., Schumacher, MA., Tominaga, M., Rosen, TA., Levine, JD., Julius, D. (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389, 816-824.
8. Csáky, TZ. (1969) Introduction to general pharmacology. pp 17-34. Appleton-Century-Craft Educational Division, Meredith Corporation, New York.
9. 13C-labeled octanoid acid breath test. J. Physiol. Paris 93, 455-460.
10. Dömötör, A, Peidl, Zs., Vincze, Á., Hunyady, B., Szolcsányi, J., Szekeres, Gy., Mózsik Gy. (2005) Immunohistocemical distribution of vaniloid receptor, calcitoni- gene related peptide and substance P in gastrointestinal mucosa of patients with different gastrointestinal disorders. Inflammopharmacology 13, 161-177.
11. Dömötör, A., Kereskay, L., Szekeres, Gy., Hunyady, B., Szolcsányi, J., Mózsik, Gy. (2006) Participation of capsaicin sensitive afferent nerves in the gastric mucosa of patients with helicobacter pyloripositive or -negative chronic gastritis. Dig Dis Sci. 52, 411-417.
12. Dömötör, A., Szolcsányi, J., Mószik, Gy. (2006) Capsaicin and glucose absortion and utilization in healthy human subjects. Eur. J. Pharmacol. 534, 280-283
13. Fisher, MA., Hunt, JN. (1976) A sensitive method for measuring haemoglobin in the gastric juice. Digestion 14, 409-414.
14. Gabella, G., Pease, H. (1973) Number of axons in the abdominal vagus of the rat. Brain, Re. 58, 465-469.
15. Grijalva, C.V., Novin, D. (1990) The role of hypothalamus and dorsal vagal complex in gastrointestinal function an pathophysiology. Ann. N. Y. Acad. Sci. 597, 207-221.
16. Hollander, F. (1934) The component of gastric secretion. Am. J. Dig Dis Sci 1, 319-329.
17. Holzer, P. (1998) Neural emergency system in the stomachs, Gastroenterology 114, 823-839.
18. Holzer, P. (1999) Capsaicin cellular targets, Mehanisms of action, as selectivity for thin sensory neurons, Phamacol. Re. 43. 143-201.
19. Hossenbocus, A., Fitzpatrick, P., Colin-Jones, DG. (1975) Measurement of gastric potencial difference at endoscopy. Gut 14, 410-415.
20. Inui, T., Kinoshita, J., Yamahuchi, A., Yamatani, T., Chiba, T. (1991) Linkage between capsaicin-stimulated calcitonin gene-related peptide and somatostatin release in the rat stomach. Am J. Physiol. 261, G770-774.
21. Jancsó, N., Jancsó- Gábor, A., Szolcsányi, J. (1967) Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Brit. J. Pharmacol. 31, 138-151.
22. Jancsó, N., Jancsó- Gábor, A., Szolcsányi, J. (1968) The role of sensory nerves endings in the neurogen inflammation induced in human skin and in the eye and paw of the rat. Brit. J. Pharmacol. 33, 32-41.
23. Jancsó-Gábor, A., Szolcsányi, J., Jancsó, N. (1970) Irrevesible impairement of the irregulation induced by capsaicin and similar pungent substances in rat and guinea-pigs. J. Physiol. (London) 206, 495-507.
24. Karádi, O., Mózsik, Gy. (2000) Surgical and chemical vagotomy on the gastrointestinal mucosal defense. Akadémiai Kiadó, Budapest. Kawai, S., Nishida, S., Kato, M., Furumaya, Y., Okamoto, R., Koshino, T., Mizushima, Y. (1998) Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells. Eur J. Pharmacol. 347, 87-94.
25. Mózsik, Gy. (2006) Molecular pharmacology and biochemistry of gastroduodenal mucosal damage and protection in Discoveries in Gastroenterology: from Basic Research to Clinical Perspectives (1960-2005) Mózsik Gy. (Ed), pp. 139-224. Akadémiai Kiadó, Budapest.
26. Mózsik, Gy., Abdel-Salam, O. M. E., Szolcsányi, J. (1997) Capsaicin-Sensitive Afferent Nerves in Gastric Mucosal Damage and Protection. Akadémiai Kiadó Budapest.
27. Mózsik, Gy., Belágyi, J., Szolcsányi, J., et al. (2004a) Capsaicin-sensitive afferent nerves and gastric mucosal protection on human healthy subjects. A critical overview, in: Mediators in Gastrointestinal Protection and Repair. Takeuchi K., Mózsik Gy., (Eds), pp. 43-62. Research Signpost, Kerala, India.
28. Mózsik, Gy., Debreceni, A., Abdel-Salam, OME., Szabó, I., Figler, M., Ludány, A., Juricskay, I., Szolcsányi, J. (1999) Small doses capsaicin given intragastrically inhibit gastric basal gastric secretion in healthy human subject. J. Physiol. Paris 93, 433-436.
29. Mózsik, Gy., Berstad, A., Myren, J., Setekleiv, J. (1969a) Absorption and urinary excretion oxyphencyclamin HCI in patients before and after a prolonged oxyphencyclimide treatment. Med Exp 19, 10-16.
30. Mózsik, Gy., Hunyady, B., Garamszegi, M., Németh, A., Pakodi, F., Vincze, A. (1994) Dynamism of cytoprotective and antisecretory drugs in patients with un healed gastric and duodenal ulcers. J Gastroenterol Hepatol 9, S88-92.
31. Mózsik, Gy., Jávor, T. (1969b) Development of drug cross-tolerance in patients treated chronically with atropine. Eur. J. Pharmacol. 6, 169-174.
32. Mózsik, Gy., Jávor, T., Dobi, S. (1965) Clinical-pharmaological analysis of long term parasympatholytic treatment. Acta Tertii Conventus Medicinae Internae Hungarici. Gastroenterologia 709-715.
33. Mózsik, Gy., Jávor, T., Dobi, S., Petrássy, K., Szabó, A. (1976) Development of "pharmacological denervation phenomenon" in patients treated with atropine. Eur. J Pharmacol. 1, 391-395.
34. Mózsik, Gy., Moron, F., Jávor, T. (1982) Cellular mechanisms of the development of gastric mucosal damage and of gastroprotection induced by prostacyclin in rats. A pharmacological study, Prostagland. Leukot. Med. 9, 71-84.
35. Mózsik, Gy., Pár, A., Pár, G. at al. (2004a) Insight into the molecular pharmacology to drugs acting on the afferent and efferent fibres of vagal nerve in the gastric mucosal protection in: Ulcer Research, Proceedings of the 11th International Conference, Sikiri P., Seiwerth P., Mózsik Gy., Arakawa T., Takeuchi K. (Eds), pp. 163-168. Monduzzi, Bologna.
36. Mózsik, Gy., Sarlos, P., Racz, I., Szolcsányi, J. (2003) Evidence for the direct protective effect of capsaicin in human healthy subjects, Gastroenterology 124 suppl. 1, A-454
37. Mózsik, Gy., Rácz, I., Szolcsányi, J. (2005) Gastroprotection induced by capsaicin in human healthy subjects. World J. Gastroenterol. 11, 5180-5184.
38. Mózsik, Gy., Vincze, Á., Szolcsányi, J. (2001) Four responses of capsaicin sensitive primary afferent neurons to capsaicin and its analog. Gastric acid secretion, gastric mucosal damage and protection. J. Gastroenterol. Hepatol. 16, 193-197.
39. Myren, J. (1968) Gastric secretion following stimulation with histamine, histology and gastrin in man. The Physiology of gastric Secretion. Semb, L. and Myren, J. (Eds) pp 413-428. Universitet forlaget, Oslo.
40. Nagy, L., Mózsik, Gy., Feledi, É., Ruzsa, Cs., Vezekényi, Zs., Jávor, T. (1984) Gastric microbleeding measurements during one day treatment with indomethacin and indomethacin plus sodium salicylate (1:10) in patients. Acta Physiol. Hung 64, 373-377.
41. 2-receptor antagonist activity, Arzneim. Forsch., Drug. Res. 49, 519-526.
42. 2-receptor antagonist, in rats, Jpn. J. Pharmacol. 68, 161-173.
43. Patty, I., Tárnok, F., Simon., Jávor, T., Deák, G., Benedek, Sz., Kenéz, P., Nagy, L., Mózsik, Gy. (1984) A comporative dynamic study of the effectiveness of gastric sytoprotection by the vitamin A, De-Nol, sucralfate and ulcer healing by pirenzepine in patients with chronic gastric ulcer (A multiclinical and randomized study) Acta Physiol Hung 64, 379-384.
44. Sarlós, P., Rumi, Gy., Szolcsányi, J., Mózsik, Gy., Vincze, Á. (2003) Capsaicin prevents the indomethacin-induced gastric mucosal damage n human healthy subject. Gastroenterology 124, Suppl. 1, A-511.
45. Sipos, G., Altdorfer, K. Pongor, É., Chen, LP., Fehér, E. (2006.) Neuroimmune link in the mucosa of chronic gastritis with Helicobacter pylori infection. Dig Dis Sci. 51, 1810-1817.
46. Szállasi, A., Blumberg, M. (1999) Vanilloid (capsaicin) receptors and mechanisms. Pharmacol. Rev. 51, 159-211.
47. Szolcsányi J. (1984): Capsaicin sensitive chemoprotective neural system with dual sensory-afferent function. In: Chalh L.A., Szolcsányi J., Lembeck F. (Eds) Antidromic Vasodilatation and Neurogenic Inflammation. Budapest, Akadémiai Kiadó, pp. 27-56.
48. Szolcsányi, J. (1997) A pharmacological approach to elucidation of the role of different nerve fibres and receptor endings inmediation of pain. J. Phisiol. Paris 73, 251-259.
49. Szolcsányi, J. (2004) Forty years in capsaicin research for sensory pharmacology and physiology. Neuropeptide 38, 377-384.
50. Szolcsányi, J., Barthó, L. (1979) Capsaicin-sensitive innervation of the guinea-pig small intestine and its selective blockade by capsaicin. Naunyn-Schmidedeberg's Arch. Pharmacol. 305, 83-90.
51. Szolcsányi, J., Barthó, L. (1981) Impaired defense mechanisms to peptic ulcer in the capsaicin-desensitized rat. in: Advances in Physiological Sciences Vol.29, Gastrointestinal Defense Mechanisms, Mózsik, Hänninan, Jávor (Eds), pp. 39-51. Pergamon Press, Oxford-Akadémiai Kiadó, Budapest.
52. 2-receptor antagonist: mucosal protection thronghout GI mucosal mediated by capsaicin-sensitive afferent nerves, Acta Pharmacol. Sinica Suppl. 27-35
53. Tárnok, F., Deák, G., Jávor, T., Mózsik, Gy., Nagy, L., Patty, I. (1983) Effect of combination atropine and cyproheptadine and atropine+carbenoxolone in duodenal ulcer therapy. Int. J. Tiss. React. 5, 315-321.
54. Tárnok, F., Jávor, T., Mózsik, Gy., Nagy, L., Patty, I., Rumi, Gy., Solt, I. (1979) A prospective multiclinical study comparing the effects of placebo, carbenoxolone, atropine cimetidine in patients with duodenal ulcer. Drugs Exp Clin Res 5, 157-166.
55. 2-receptor antagonist. Dig. Dis. Sci. 35, 976-983.